Grant application success!

Kristina Medlinskiene, previous course attendee

Writing a grant application for the first time is not easy to say the least (or maybe it never gets easy). I recall my very early start on this endeavour with very rough knowledge of what it may entail. The RPS two-day research proposal workshop gave me clarity but it also raised many more questions about issues I hadn’t even thought about!

Patient public involvement group? Advisory group? Before the workshop I had not thought about forming these groups or had any idea how to do it. Methodology? Theoretical framework? Detailed costs of the project? Just a few things that I needed to find answers to.

The format of the two days stimulated thinking about your project and the grant application. Most importantly it gave me a direction, a sense of ‘right, this is clearer now’. By the end of the two days I had a preliminary action plan with identified crucial tasks that I needed to address first.

The two days consisted of presentations and workshops covering various topics from how to build a case for the funding application, to the data processing and analysis. Whilst some topics were covered briefly, I read more about it in the book provided and referred back to it for some quick pointers.

Personally, the biggest benefit of attending the two-day workshop alongside the workshops was networking. You not only get a chance to meet and hear experiences of pharmacists who have gone through the process but also ask them for advice later when you are writing your application and get stuck! They were incredibly helpful.

As I have learnt writing a grant application requires a lot of commitment, persistence and some sleepless nights. Get all the help you can, even if it means pushing barriers of your confidence!

If you don’t know how to start writing an application, these workshops could be what you need. They helped me with my application writing.

The RPS will be running a research proposal writing workshop on the 6-7th March 2018. See our events page for more information and to book your place. This course has very limited numbers so please don’t hesitate and secure yours now. We want to ensure you get the grant funding you deserve by writing a successful grant application.

Community pharmacy: a gateway to health

by  Gill Hawksworth MBE, FRPharmsS and RPS Faculty Fellow

I have been trying to keep track of a gradual change in attitudes about pharmacy and public health and now,18 months on from when the Murray Review was commissioned, find myself asking ‘What does it all mean?’.

In September 2017, several key announcements began with the new Pharmacy Minister Steve Brine who said at the RPS conference that initiatives such as the work of (HLP) and flu vaccination services highlight pharmacy’s role in promoting public health and reducing health inequalities. Also at the Labour party conference, the Pharmacy APPG Chair  and Labour MP for Rother Valley, Kevin Barron, said they would like to see the HLP initiative included in the community pharmacy contract as it has a ‘role to play in improving public health’. This was encouraging, so the message must be getting through somehow to those who could influence change and this is backed up by the news that the Public Health England (PHE) report ‘Pharmacy: A Way Forward for Public Health’ has been published.

This new report sets out opportunities for commissioners, some of whom have previously decommissioned such services, to realise community pharmacy’s role in protecting and improving the nation’s health, flagging up growth in the HLP programmes since a quality payment is now available for attaining HLP1 status. The CPPE are supporting this with leadership for HLP workshops and the paper also looks at developing capacity in the workforce to support promoting health through pharmacy settings and lists smoking cessation among the menu of opportunities for community pharmacists to get involved, timely for the PHE Stoptober challenge.

PHE is working with the Pharmacy and Public Health Forum to collect case studies of promising practice to help identify opportunities to build on current learning and scale what is working and has been shown to have impact.  Interestingly there is already a move in Scotland (the vision of Achieving Excellence in Pharmaceutical Care) to expand the public health role with evidenced-based interventions, so pharmacy is at the heart of delivering national health and well-being priorities.

A further focus in September was on support for the role of community pharmacists in antimicrobial stewardship, highlighted in the RPS national campaign, and again during World Antibiotic Awareness Week this week.

There was also an article by Professor David Wright (who’s literature review informed the Murray Review) on the potential for revised Medicines Use Reviews (MURs). We must remember that a range of public health interventions are often part of an MUR. This can include looking after the mental health and wellbeing, as well as physical health, of elderly patients who may be lonely, supported by CPPE’s work on mental health. This also offers a chance for pharmacists to fulfil other roles such as in cancer awareness and screening referral.

Making every contact count and documenting public health interventions may be a good place to start and help to develop the evidence base, remembering that the Murray Review stated ‘we should note that the evidence for (or against) specific clinical services within the peer-reviewed literature is often relatively sparse’.

All this is developing within the context of RPS working with PHE and NHS England to promote the role of pharmacists in public health, with the support of the RPS Professional Standards for Public Health Practice for Pharmacy.

So as attitudes are gradually changing and funding of public health services are being considered in terms of the evidence available, I await, with interest, the public consultation I understand is coming soon on the work by NICE on community pharmacy public health interventions. This deals with the evidence, (RCTs as gold standard) therefore relying on documentation of public health interventions such as alcohol, sexual health and of course smoking. After all, community pharmacists I believe have a good track record in helping people stop smoking.

Pharmagraphics

By Briony Hudson, Pharmacy historian, curator and lecturer

What do mandrake, medicinal treacle and the RPS headquarters have in common?

They all feature in Pharmagraphics , a new online “digital story” from the Wellcome Collection that explores the relationship between pharmacy and design across time.

I started work on the project with Julia Nurse, Wellcome Library’s Collections Researcher, earlier this year to produce six “chapters” that looked at different aspects of pharmacy history and how graphics, design and imagery played their part.  The aim was to link with the Wellcome Collection’s current exhibition ‘Can Graphic Design Save Your Life?’, and to draw on the fantastic collection of images both within Wellcome’s own collection and elsewhere including the Royal Pharmaceutical Society Museum . Read more Pharmagraphics

Biologics and biosimilars – what are they?

By Jayne Lawrence, Head of Division of Pharmacy and Optometry, University of Manchester.

The Commissioning Framework for Biological Medicines announced recently by NHS England will both help guide improvements to developing better medicines for patients and provide a guide to ensuring the NHS gets best value for money from these innovative, exciting medicines.

What is a biologic?
Biological medicines have made many new, groundbreaking treatments possible, significantly im-proving the lives of many patients with long term conditions such as diabetes, arthritis, anaemia associated with chronic kidney failure, and types of cancer.

They are extremely expensive, in part due to the complexity of their production. For example, a course of a new immunotherapy drug typically costs more than £100,000 per patient per year. Furthermore, as biologicals currently comprise approximately 50% of all new drug approvals, it is likely that the high cost of new medicines is with us for the foreseeable future. Consequently, any way of reducing the cost of these important medicines is vital. Read more Biologics and biosimilars – what are they?

Integrative medicine approach to treating cancer patients

By Louisa Davies, Senior Clinical Oncology Pharmacist at University College of London Hospital

I love my job! I’ve been a qualified clinical pharmacist for 12 years and am very fortunate to work at the wonderful Macmillan Cancer Centre at University College Hospital in London as a specialist oncology pharmacist. I find it immensely rewarding as every day is an opportunity to support someone along their cancer journey.

I have a personal interest in wellness and the growing use of supplements for health and over the past few years I have seen more and more patients adopting an integrative approach to their cancer care. At UCLH we recorded that around 35% of patients we saw in clinic were taking or wanted to start taking supplements to improve their side effects or boost their immunity whilst on anti cancer therapy. Read more Integrative medicine approach to treating cancer patients

Why is handwashing important?

By Professor Ash Soni, President of the Royal Pharmaceutical Society

Every day we carry millions of bacteria, some of which are naturally found on our bodies and some of which are germs that can make us ill or infect others.

Every day we have contact with people who don’t always wash their hands after going to the toilet, or preparing food.

Our survey on handwashing shows 84% of British adults don’t wash their hands for long enough to clean them of bacteria which can cause infections such as upset stomachs or pneumonia, or viruses which can cause colds and flu.

Regular handwashing with soap and water is the single best way to protect yourself and others from infections. The recommended time to spend washing your hands is 20 seconds, as long as it takes to sing ‘Happy Birthday to you’ twice. Read more Why is handwashing important?

Creating a profession where you feel comfortable to be yourselves

by Robbie Turner, RPS Director for England

Recently I wrote a blog about  LGBTQ Pride celebrations describing how upset I was that LGBTQ young people were still suffering high levels of abuse, discrimination and mental health issues as a result of their identity. I promised to reflect on what more the RPS could do to support pharmacists to help young LGBTQ people and we are exploring how our future RPS campaigns can deliver this. Read more Creating a profession where you feel comfortable to be yourselves

What do pharmacists need to know about heartburn?

By Dr Pulak Sahay, Consultant Gastroenterologist and Senior Lecturer of Medicine, Leeds University

What is reflux?

It is estimated that there are over 10 million adults in the UK who suffer from heartburn (sometimes known as reflux disease or Gastro-Oesophageal Reflux Disease (GORD)).  If left untreated or poorly controlled, this can cause considerable discomfort and lead to a poor quality of life. In extreme situations, untreated heartburn can cause a host of both gastrointestinal (GI) and non-GI complications, including severe complications such as Oesophageal Adenocarcinoma (OA) – known as Oesophageal Cancer. Read more What do pharmacists need to know about heartburn?

Pharmacy’s future is digital

By Sibby Buckle, Chair of the RPS Digital Forum

 

What is the RPS Pharmacy Digital Forum?

It’s where the profession comes together to forge the future.  We are an enthusiastic and committed group of 30+ members who agree that digital literacy across the profession needs urgent attention.

With representation from across the UK, and from all sectors of pharmacy – community, primary care and hospital, PMR suppliers, NHS Digital, DH, PSNC, PRSB, and NHS Improvement –  there is a real appetite to create the change needed to enable pharmacy to be truly integrated into the NHS and healthcare. Read more Pharmacy’s future is digital

Write a winning abstract for conferences

Poster display

Write a winning abstract and submit for our inaugural Winter Summit.

Want to hear about the latest innovations in medicines and pharmacy? Looking to get your M.Pharm project published in an international journal? Interested in a career in academia or pharmaceutical science?

Explore the latest innovations in pharmaceutical science and research and get your work published. Join us for the RPS Winter Summit!

 

A new event in the RPS calendar, the Winter Summit will bring together experts from within pharmacy and pharmaceutical science for a programme of cutting edge topics: big data, drug development and the future of education to name a few.

Submit an abstract

Abstract submissions for oral or poster presentation are welcomed from across the science and research spectrum, so whether you have been working in the lab or on a patient-facing project, we have an opportunity for you.

  • Pharmaceutical science and early stage clinical research will be published in the Journal of Pharmacy and Pharmacology (Impact Factor 2.405)
  • Health service research and pharmacy practice will be published in the International Journal of Pharmacy Practice

For more information about the submissions process and guidance visit the webpage here

Get help from the RPS in writing your abstract

  • So what is an abstract? An abstract is a concise summary of a project that allows readers to quickly identify its novelty, rigour and potential impact. Writing an abstract is an opportunity to share evidence widely and is a key component of most professional conferences; it is also an excellent starting point for those new to research looking to get their work recognised.
  • Writing winning abstracts. An abstract should be a summary of a project with a clear aim and concise design, method and results with meaningful conclusion.

Join us on September 7th for an instructional webinar to help prepare your abstract. The webinar will review abstract structure and give helpful tips on judging criteria and common pitfalls

Submit your abstract by 5pm GMT on 11 September or book now to secure your place at the Winter Summit 2017.